CXCL5 suppression recovers neovascularization and accelerates wound healing in diabetes mellitus
暂无分享,去创建一个
[1] Jaw-Wen Chen,et al. CCL4 Deletion Accelerates Wound Healing by Improving Endothelial Cell Functions in Diabetes Mellitus , 2022, Biomedicines.
[2] T. Battelino,et al. Pathogenesis of Type 1 Diabetes: Established Facts and New Insights , 2022, Genes.
[3] César Martín,et al. Pathophysiology of Type 2 Diabetes Mellitus , 2020, International journal of molecular sciences.
[4] P. Proost,et al. Neutrophil chemoattractant receptors in health and disease: double-edged swords , 2020, Cellular & Molecular Immunology.
[5] Yu-Ming Li,et al. ENA-78 Is a Novel Predictor of Wound Healing in Patients with Diabetic Foot Ulcers , 2019, Journal of diabetes research.
[6] Liang-Yu Lin,et al. Inhibition of macrophage inflammatory protein-1β improves endothelial progenitor cell function and ischemia-induced angiogenesis in diabetes , 2018, Angiogenesis.
[7] G. Chrousos,et al. On type 1 diabetes mellitus pathogenesis , 2017, Endocrine connections.
[8] H. Nagai,et al. Exacerbation and Prolongation of Psoriasiform Inflammation in Diabetic Obese Mice: A Synergistic Role of CXCL5 and Endoplasmic Reticulum Stress. , 2017, The Journal of investigative dermatology.
[9] M. Ochi,et al. The Use of Endothelial Progenitor Cells for the Regeneration of Musculoskeletal and Neural Tissues , 2017, Stem cells international.
[10] Shaoling Yang,et al. Pathophysiology of peripheral arterial disease in diabetes mellitus , 2017, Journal of diabetes.
[11] G. Ramage,et al. The Influence of Glycated Hemoglobin on the Cross Susceptibility Between Type 1 Diabetes Mellitus and Periodontal Disease. , 2015, Journal of periodontology.
[12] O. Tabatabaei-Malazy,et al. Association between Genetic Variants and Diabetes Mellitus in Iranian Populations: A Systematic Review of Observational Studies , 2015, Journal of diabetes research.
[13] E. Armstrong,et al. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. , 2015, World journal of diabetes.
[14] S. Kinlay,et al. Endovascular intervention for peripheral artery disease. , 2015, Circulation research.
[15] E. Rojewska,et al. The Role of Some Chemokines from the CXC Subfamily in a Mouse Model of Diabetic Neuropathy , 2015, Journal of diabetes research.
[16] C. Nunemaker,et al. Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function. , 2014, The Journal of endocrinology.
[17] G. King,et al. Vascular complications of diabetes: mechanisms of injury and protective factors. , 2013, Cell metabolism.
[18] E. Elster,et al. Comparative analysis of angiogenic gene expression in normal and impaired wound healing in diabetic mice: effects of extracorporeal shock wave therapy , 2010, Angiogenesis.
[19] Hsiao-Ya Tsai,et al. Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow–Derived Endothelial Progenitor Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[20] L. Fajas,et al. CXCL5 drives obesity to diabetes, and further , 2009, Aging.
[21] M. Muraguchi,et al. Increased urinary levels of CXCL5, CXCL8 and CXCL9 in patients with Type 2 diabetic nephropathy. , 2009, Journal of diabetes and its complications.
[22] E. Renard,et al. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. , 2009, Cell metabolism.
[23] A. Alfadda,et al. Circulatory neutrophil chemokines in statin-treated diabetic patients. , 2008, Saudi medical journal.
[24] S. Rafii,et al. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. , 2007, Trends in immunology.
[25] G. Gurtner,et al. Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.
[26] Alan W. Stitt,et al. Advanced glycation end products and diabetic complications , 2002, Expert opinion on investigational drugs.
[27] A. Walz,et al. Regulation and function of the CXC chemokine ENA‐78 in monocytes and its role in disease , 1997, Journal of leukocyte biology.
[28] R. Strieter,et al. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8 , 1991, The Journal of experimental medicine.
[29] I. Zineh,et al. CXCL5 Gene Polymorphism Association with Diabetes Mellitus , 2012, Molecular Diagnosis & Therapy.
[30] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..